Significant Contract Modifications ($10M+) — September 05, 2026

Blue Origin secured a $660M firm-fixed-price contract for Mars Sample Return, beating full-and-open competition. This signals strong technical capability and potential for follow-on deep-space work, though zero funds outlayed adds execution risk.

Integrated Quality Solutions, a self-certified small disadvantaged business, won a $162M firm-fixed-price contract under full-and-open competition for pharmaceutical logistics, signaling potential for further GSA FEDSIM awards.

General Dynamics Information Technology’s $440M cost-plus contract for NAVAIR engineering services ends in 2021-2022, with only $33M outlayed. This maturing contract provides no forward revenue catalyst for GD.

PAE Professional Services (Amentum) has a $224M fixed-price USCIS contract with only $59M outlayed, suggesting potential underperformance or delayed funding. Fixed-price structure shifts cost risk to Amentum.

Blue Origin’s $660M fixed-price Mars contract has zero funds outlayed, creating risk of milestone delays or cost overruns that could pressure margins.

PAE/Amentum’s $224M fixed-price USCIS contract has only $59M outlayed (26% of obligation), indicating potential operational underperformance or funding delays.

Three of four contracts are civilian (NASA, GSA, USCIS), exposing the digest to non-defense budget risk. Only one defense contract (GDIT/NAVAIR) is included.

Blue Origin’s Mars win positions it for future NASA deep-space contracts, including potential crewed Mars missions. The contract’s extension to 2035 offers long-term revenue visibility if milestones are met.

Integrated Quality Solutions’ $162M GSA contract for pharmaceutical logistics (Site G) suggests a series of similar awards. Follow-on contracts for other sites could multiply revenue.

GDIT’s legacy NAVAIR contract ending in 2022 creates a re-compete opportunity. A new solicitation could allow GDIT or competitors to bid for follow-on engineering services.

NASA’s $660M fixed-price award to Blue Origin for Mars Sample Return signals a shift toward commercial partnerships for deep-space missions, increasing performance risk but also upside for successful contractors.

GSA’s $162M award to Integrated Quality Solutions for pharmaceutical logistics underscores federal investment in cold chain and emergency response infrastructure, a stable civilian growth area.

{"entity" => "Blue Origin LLC", "reason" => "$660M NASA Mars contract with zero funds outlayed; execution risk is high.", "trigger" => "NASA FY2027 budget mark-up; Blue Origin design review milestones; any subcontractor awards"}

{"entity" => "General Dynamics Information Technology", "reason" => "Legacy $440M NAVAIR contract ending 2021-2022; re-compete opportunity or loss could affect GDIT revenue.", "trigger" => "NAVAIR CSM re-compete solicitation; GDIT earnings calls for contract backlog updates"}

{"entity" => "PAE Professional Services / Amentum Holdings", "reason" => "$224M USCIS contract with only $59M outlayed; potential underperformance or funding delay.", "trigger" => "USCIS contract modification announcements; Amentum quarterly earnings for margin commentary"}

{"entity" => "Integrated Quality Solutions LLC", "reason" => "New $162M GSA contract; option exercises and follow-on site awards will determine revenue trajectory.", "trigger" => "GSA option exercise announcements; any new Site G or Site H solicitations"}